Single-center, prospective comparative study for detection ability of hepatocellular carcinoma between abdominal ultrasonography and endoscopic ultrasonography

Single-center, prospective comparative study for detection ability of hepatocellular carcinoma between abdominal ultrasonography and endoscopic ultrasonography - Single-center, prospective comparative study for detection ability of hepatocellular carcinoma between abdominal ultrasonography and endoscopic ultrasonography

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000033250

Enrollment

147

Registered

2018-07-03

Start date

2018-07-18

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

Abdominal ultrasonography (including contrast-enhanced abdominal ultrasonography) 1 time. Endoscopic ultrasonography (including contrast-enhanced endoscopic ultrasonography) 1 time.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Diagnosed with hepatocellular carcinoma using contrast-enhanced CT and/or Gd-EOB-MRI. Within 3 tumors. Informed consent must be obtained from patients themselves. Eastern Cooperative Oncology Group performance status 0-2.

Exclusion criteria

Exclusion criteria: Difficult to endoscopic ultrasonography. Difficult to gastrointestinal endoscopy. Presence of esophageal varices with F2, F3 and/or red color sign. Presence of sever organopathy. Difficult to obtain informed consent. Ineligible cases are judged by researchers.

Design outcomes

Primary

Measure	Time frame
Difference of detection rate of hepatocellular carcinoma between contrast-enhanced abdominal ultrasonography and contrast-enhanced endoscopic ultrasonography	—

Countries

Japan

Contacts

Public ContactRyo Shimizu

Wakayama Medical University Second Department of Internal Medicine

rshimizu@wakayama-med.ac.jp+81-73-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026